Showing results (951-960 of 1,136) with videos related to

Sort By:
Pageof 114
JBMR Plus|June 10, 2024
Irisin prevents trabecular bone damage and tumor invasion in a mouse model of multiple myelomaRoberta Zerlotin, Angela Oranger, Patrizia Pignataro, et al.
Biomolecules|August 26, 2022
Circulating Irisin Levels in Patients with Chronic Plaque PsoriasisFrancesca Ambrogio, Lorenzo Sanesi, Angela Oranger, et al.
Chemmedchem|July 9, 2013
Chemical, pharmacological, and in vitro metabolic stability studies on enantiomerically pure RC-33 compounds: promising neuroprotective agents acting as σ₁ receptor agonistsDaniela Rossi, Alice Pedrali, Raffaella Gaggeri, et al.
Molecules (Basel, Switzerland)|February 26, 2020
Insight into GEBR-32a: Chiral Resolution, Absolute Configuration and Enantiopreference in PDE4D InhibitionValeria Cavalloro, Katia Russo, Francesca Vasile, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 19, 2015
Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkersAlberto Dal Corso, Michele Caruso, Laura Belvisi, et al.
Journal of Assisted Reproduction and Genetics|May 3, 2023
Humidified atmosphere in a time-lapse embryo culture system does not improve ongoing pregnancy rate: a retrospective propensity score model study derived from 496 first ICSI cyclesAlessandro Bartolacci, Andrea Borini, Danilo Cimadomo, et al.
Annals of Neurology|May 23, 2024
Irisin Levels in Cerebrospinal Fluid Correlate with Biomarkers and Clinical Dementia Scores in Alzheimer DiseaseManuela Dicarlo, Patrizia Pignataro, Chiara Zecca, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2018
Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boysAdriana María Belén Abiuso, María Luisa Varela, Luis Haro Durand, et al.
Acta Neuropathologica Communications|May 29, 2025
Acute targeting of N-terminal tau protein has long-lasting beneficial effects in Tg2576 APP/Aβ mouse model by reducing cognitive impairment, cerebral Aβ-amyloidosis, synaptic remodeling and microgliosis later in lifeValentina Latina, Margherita De Introna, Francesca Malerba, et al.
The British Journal of Ophthalmology|June 5, 2026
Proactive treatment regimen with dexamethasone implant for diabetic and post-occlusive macular oedema: the ProDEX-2 studyPasquale Viggiano, Tunde Peto, Mariagrazia Pignataro, et al.
Pageof 114